ALLHAT and JNC 7: Health-system applications and economic considerations

News
Article

New Orleans-The results of the Antihypertensive and Lipid-Lowering Treatmentto Prevent Heart Attack (ALLHAT) Trial, along with the highlights of theSeventh Report of the Joint National Committee on Prevention, Detection,Evaluation, and Treatment of High Blood Pressure (JNC 7), were presentedon Dec. 9 at an educational session of the 38th ASHP Midyear Clinical Meeting.

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.